
Daoride-PM 2mg/500mg/75mg Tablet
Marketer
Azine Healthcare Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (75mg)
Overview Daoride-PM 2mg/500mg/75mg Tablet
Glycaemic Control tablets (2mg/500mg/75mg) combine medications to manage blood glucose. This formulation, used alongside diet and exercise, enhances blood sugar regulation in adults with type 2 diabetes. It facilitates efficient insulin use, resulting in lower blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Take with food to prevent digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; in that case, omit the missed dose and resume the regular regimen. Never double the dose; overdose risks hypoglycemia (low blood sugar). Concurrent use with other antidiabetic drugs, alcohol, or skipped meals elevates hypoglycemia risk; consistent blood glucose monitoring is crucial. Common side effects may include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Pre-existing kidney, liver, or heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Kidney function tests will be assessed before treatment begins. Limit alcohol consumption to mitigate potential side effect intensification.
Uses of Daoride-PM 2mg/500mg/75mg Tablet
Managing Type 2 Diabetes
Major Benefits of Daoride-PM 2mg/500mg/75mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Daoride-PM 2mg/500mg/75mg tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
Common Side effects of Daoride-PM 2mg/500mg/75mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Daoride-PM 2mg/500mg/75mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Daoride-PM 2mg/500mg/75mg tablet should be administered with a meal.
How Daoride-PM 2mg/500mg/75mg Tablet works:
Daoride-PM 2mg/500mg/75mg tablets combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining alcohol and Daoride-PM 2mg/500mg/75mg tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Daoride-PM 2mg/500mg/75mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Daoride-PM 2mg/500mg/75mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is possible with excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Individuals with impaired kidney function should exercise caution when using Daoride-PM 2mg/500mg/75mg tablets, as dose modification may be necessary. Consult a physician for guidance. Daoride-PM 2mg/500mg/75mg tablets are contraindicated in patients with severely compromised kidney function. Regular monitoring of kidney function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Daoride-PM 2mg/500mg/75mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Daoride-PM 2mg/500mg/75mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Daoride-PM 2mg/500mg/75mg Tablet :
Should you forget to take your Daoride-PM 2mg/500mg/75mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.
Facts to Know About Daoride-PM 2mg/500mg/75mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
